0
0
1/26/23 at 11:32am
Organization
NDTV News
33 words
0
Comments
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
You are the first to view
https://www.ndtv.com/india-news/bharat-biotechs-nasal-covid-vaccine-incovacc-launched-3726322
Create an account
or login to join the discussion